Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03829787 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later Sep 1, 2026 → Apr 1, 2027
See other at-risk trials from University Hospitals Cleveland Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Sep 1, 2026 to Apr 1, 2027
    • Eligibility criteria expanded, about 7 words
  2. Primary and study completion dates: Sep 1, 2025 to Sep 1, 2026
    • Site contact updated
    v8
  3. Primary and study completion dates: Sep 1, 2024 to Sep 1, 2025
    • Site contact updated
    v7
  4. Primary and study completion dates: Sep 1, 2023 to Sep 1, 2024v6
  5. Primary and study completion dates: Sep 1, 2022 to Sep 1, 2023v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: Sep 1, 2021 to Sep 1, 2022v4
  2. Primary and study completion dates: Sep 1, 2020 to Sep 1, 2021v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 1, 2019 to Mar 27, 2019
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or without anxiety and/or substance use disorder comorbidity.
Trial Details
NCT Number NCT03829787
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions
(from sponsor)		 Bipolar Disorder
Related terms Bipolar Disorder
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov